Company             Trans Chromosomics, Inc.

​​

Board Member      CEO : Mitsuo Oshimura

                          Outside Director : Nobuo Murakami

​

Founded              December 17, 2014

​​

Capital                 ¥100,000,000

​​

Employees           18

​

Business Overview

• Research and development of a platform for discovering drug candidates using chromosome engineering technology, and what comes out of it

• Creating antibody drug seeds using animals that produce fully human antibodies

• Providing mice and rats that can be used to evaluate drug effects and toxicity, and collaborating on drug development research

 

Locations　　  Located in the Tottori Pharmaceutical Innovation Center

　　　　　　  86 Nishi-cho, Yonago, Tottori 683-8503, Japan

                      Tel: +81-859-30-3494   Fax: +81-859-21-3500